cAMP-dependent protein kinase

cAMP-dependent protein kinase
Name	cAMP-dependent protein kinase
Other names	protein kinase A; PKA
Function	Serine/threonine kinase regulated by cyclic AMP
Organism	Homo sapiens

cAMP-dependent protein kinase is a ubiquitous serine/threonine kinase that mediates signaling downstream of cyclic adenosine monophosphate in eukaryotes. It is central to processes first characterized in studies involving Edwin G. Krebs, Earl W. Sutherland Jr., and biochemical work at institutions such as the National Institutes of Health and Columbia University. The enzyme integrates inputs from G protein–coupled receptors like β-adrenergic receptors and hormonal systems including epinephrine and glucagon to control metabolism, gene expression, and cell growth.

Structure and subunits

The holoenzyme is a tetrameric complex composed of two regulatory (R) subunits and two catalytic (C) subunits, a stoichiometry described in structural studies from laboratories at Harvard University and Stanford University. Mammalian genomes encode four major R isoforms (RIα, RIβ, RIIα, RIIβ) and three C isoforms (Cα, Cβ, Cγ), with genes mapped in projects at Human Genome Project–era centers such as the Wellcome Trust Sanger Institute and Broad Institute. High-resolution X-ray crystallography and cryo-EM structures solved by groups at Max Planck Institute and Cold Spring Harbor Laboratory revealed a dimerization/docking (D/D) domain, two cyclic nucleotide-binding (CNB) domains per R subunit, and a bilobal kinase fold in C subunits similar to those seen in kinases studied at European Molecular Biology Laboratory. Differential tissue expression of isoforms was characterized in studies from Johns Hopkins University and University of California, San Francisco.

Activation and regulation

Activation is initiated when intracellular cyclic adenosine monophosphate levels rise following activation of adenylyl cyclase by Gαs proteins downstream of receptors like dopamine D1 receptor and glucagon receptor. cAMP binds to CNB domains on R subunits, inducing conformational changes that release active C subunits, a mechanism elucidated in biochemical work by Edwin G. Krebs’s laboratory and structural analyses from Yale University. Regulation occurs via compartmentalization by A-kinase anchoring proteins (AKAPs) first described by laboratories at University of California, San Diego and University of Michigan, which tether holoenzymes to organelles including mitochondrion, nucleus, and plasma membrane. Feedback control involves phosphodiesterases (PDEs) characterized at Imperial College London and phosphorylation of R and C subunits by kinases such as casein kinase II and phosphatases like protein phosphatase 1.

Catalytic mechanism and substrate specificity

The catalytic subunit uses the conserved kinase catalytic machinery first described in comparative analyses by groups at Cold Spring Harbor Laboratory and Max Planck Institute of Biochemistry. ATP binds in the cleft between the N- and C-terminal lobes, and catalysis proceeds via an ordered bi-bi mechanism with coordination by Mg2+ ions, as shown in enzymology work at University of Oxford. Substrate recognition depends on a consensus sequence motif (Arg-Arg-X-Ser/Thr) identified in peptide mapping studies from Massachusetts Institute of Technology and Rockefeller University. Determinants of specificity are further modulated by AKAP-mediated localization and by regulatory phosphorylation sites characterized in proteomics screens at European Bioinformatics Institute and Proteomics Center Copenhagen.

Cellular functions and signaling pathways

PKA phosphorylates substrates across compartments to control glycogen metabolism via glycogen synthase kinase 3 and phosphorylase kinase, lipolysis via hormone-sensitive lipase, and transcription via factors such as cAMP response element-binding protein (CREB). Pathways involving PKA intersect with mitogen-activated protein kinase (MAPK) cascades, Wnt signaling, and mTOR networks described in reviews from University of Cambridge and Princeton University. In neurons, PKA regulates synaptic plasticity and memory through modulation of ion channels like the L-type calcium channel and synaptic proteins studied in laboratories at Columbia University and University College London. In cardiomyocytes, PKA phosphorylation of contractile proteins was characterized in work at Cleveland Clinic and Beth Israel Deaconess Medical Center.

Role in physiology and disease

Physiological roles span metabolism, development, immune responses, and neurobiology, with genetic defects linked to diseases. Mutations in PRKAR1A cause Carney complex, first mapped in clinical genetics studies at Mayo Clinic and National Cancer Institute. Aberrant PKA signaling associates with endocrine tumors, cardiac arrhythmias characterized by groups at Mount Sinai Hospital, and psychiatric disorders investigated at National Institute of Mental Health. Viral and oncogenic processes exploit PKA pathways; for example, aberrant cAMP signaling is implicated in prostate and breast cancers studied at Dana-Farber Cancer Institute and Memorial Sloan Kettering Cancer Center.

Pharmacology and inhibitors

Pharmacological modulation includes cAMP analogs, competitive ATP-site inhibitors, and peptide disruptors of AKAP binding developed in medicinal chemistry programs at Pfizer and Novartis. Classic inhibitors such as H-89 were characterized in pharmacology labs at Scripps Research Institute; however, off-target effects revealed in screens at GlaxoSmithKline limit their selectivity. Small molecules targeting regulatory interfaces and allosteric sites are in preclinical development by biotech firms including Amgen and academic consortia at University of Pennsylvania. Therapeutic strategies aim to modulate PKA in heart failure, metabolic disease, and cancer as pursued in clinical trials registered at National Institutes of Health.

Experimental methods and assays

Key methods include in vitro kinase assays using radiolabeled ATP developed in foundational work at Cold Spring Harbor Laboratory, phospho-specific antibodies and Western blotting refined at Stanford University, and mass spectrometry–based phosphoproteomics advanced at European Molecular Biology Laboratory. FRET-based biosensors for real-time cAMP and PKA activity were pioneered by teams at University of California, San Diego and University of Connecticut. Genetic manipulation via CRISPR/Cas9 in models from Broad Institute and conditional knockout mice from Jackson Laboratory enable in vivo functional studies. Structural determination employs X-ray crystallography and cryo-EM at facilities such as Argonne National Laboratory and Diamond Light Source.

Category:Protein kinases